Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases (Q33375927)

26 July 2017

Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases (English)

1 reference

26 July 2017

Fatih Tufan

1

1 reference

26 July 2017

Sevil Kamali

2

1 reference

26 July 2017

Burak Erer

3

1 reference

26 July 2017

Ahmet Gul

4

1 reference

26 July 2017

Murat Inanc

5

1 reference

26 July 2017

Lale Ocal

6

1 reference

26 July 2017

Meral Konice

7

1 reference

26 July 2017

Orhan Aral

8

1 reference

26 July 2017

18 July 2007

1 reference

26 July 2017

Clinical Rheumatology

1 reference

26 July 2017

26

1 reference

26 July 2017

11

1 reference

26 July 2017

1913-1915

1 reference

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

26 July 2017

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)

1 reference

12 December 2020

Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood

1 reference

12 December 2020

Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature

1 reference

12 December 2020

Intravenous immunoglobulin: adverse effects and safe administration

1 reference

12 December 2020

Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study

1 reference

12 December 2020

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

1 reference

12 December 2020

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Review: intravenous immunoglobulin therapy and thromboembolic complications

1 reference

12 December 2020

Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases

1 reference

12 December 2020

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

12 December 2020

10.1007/S10067-007-0694-Y

Identifiers

DOI

1 reference

26 July 2017

1 reference